Search - tctmd.com

Displaying 41 - 60 of 305

Sort: Relevancy | Date

Presentation TCT 2023

TCT 243: Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial

Presenter: R. Kevin Rogers

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Presenter: Gorav Ailawadi

October 24, 2023

Presentation TCT 2023

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Presenter: Martin Leon

October 24, 2023

Presentation TVT 2023

Analysis of Procedure Volume and Outcomes of Surgical and Transcatheter Aortic Valve Replacement Following Regulatory Approval of Low-Surgical Risk Patients

Presenter: Ghadi Moubarak

June 08, 2023

Presentation TVT 2023

Association of Low Geriatric Nutritional Risk Index With Transcatheter Aortic Valve Replacement Procedural Futility

Presenter: Rohit Masih

June 08, 2023

Presentation TVT 2023

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Presenter: Michael Mack

June 08, 2023

Presentation TVT 2023

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Presenter: Firas Zahr

June 08, 2023

Presentation ACC 2023

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Presenter: John K. Forrest

March 05, 2023

Presentation TCT 2022

Case Presentation: A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis

Presenter: Tom Cahill

September 18, 2022

Presentation TCT 2022

TCT 758: Low Contrast Protected PCI Combining DES and DEB for the Treatment of Severely Calcified Left Main and Multivessel Disease in a High-Risk Patient

Presenter: Ottavia Cozzi

September 17, 2022

Presentation TCT 2022

Case #2: MVD With Low Ejection Fraction (High-Risk for CABG)

Presenter: Arnold Seto

September 17, 2022

Presentation TVT 2022

Key features for a first valve in a low-risk patient

Presenter: Katherine Harrington

June 09, 2022

Presentation CTO 2022

Shockwave in CTOs: Role of IVL in the Subintimal Space

Presenter: Jonathan Hill

February 25, 2022

Presentation CTO 2022

Concomitant Strategy to LAD and Diagonal Calcium Modification

Presenter: Rhian Davies

February 25, 2022

Presentation CTO 2022

Calcium Modification in a LM Trifurcation of an ACS Patient with MCS

Presenter: Robert Riley

February 25, 2022

Presentation CTO 2022

Hemodynamic fundamentals for High-Risk PCI in advanced CKD

Presenter: Megha Prasad

February 25, 2022

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

Presentation TCT 2021

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

Presenter: Joanna Chikwe

November 05, 2021

Advertisement

TCT 243: Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial

Four-Year Outcomes From the EVOLUT Low Risk Trial

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Analysis of Procedure Volume and Outcomes of Surgical and Transcatheter Aortic Valve Replacement Following Regulatory Approval of Low-Surgical Risk Patients

Association of Low Geriatric Nutritional Risk Index With Transcatheter Aortic Valve Replacement Procedural Futility

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Case Presentation: A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis

TCT 758: Low Contrast Protected PCI Combining DES and DEB for the Treatment of Severely Calcified Left Main and Multivessel Disease in a High-Risk Patient

Case #2: MVD With Low Ejection Fraction (High-Risk for CABG)

Key features for a first valve in a low-risk patient

Shockwave in CTOs: Role of IVL in the Subintimal Space

Concomitant Strategy to LAD and Diagonal Calcium Modification

Calcium Modification in a LM Trifurcation of an ACS Patient with MCS

Hemodynamic fundamentals for High-Risk PCI in advanced CKD

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content